Inotiv, Inc.

West Lafayette, IN Inotiv, Inc.

UEI
QYU7HDLDQK16
CAGE
58516
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Show all
Corporate family
SAM.gov registration date
Physical address
2701 Kent Ave, West Lafayette, IN 47906, USA
Website
basinc.com
Founded
1974
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Inotiv, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Non-GLP 3-strain ames assay Contract · 68HE0B25P0363 Office of Research and Development $12,000
Lab services Contract · 75D30124P19811 CDC Pittsburgh $22,830
Development of APOL1 mouse platform for focal segmental glomerulosclerosis and chronic kidney disease advances Grant · HT94252410205 Defense Health Agency $1,835,034
Pathology evaluation of mice lungs Contract · 75D30124P18947 CDC Pittsburgh $35,860
Non-GLP ames assay services Contract · 68HE0B24P0309 Office of Research and Development $12,000

About Inotiv, Inc.

Inotiv, Inc. is a for-profit contract research organization and manufacturer of goods specializing in biomedical research, drug discovery, and development services for federal agencies. Registered in SAM.gov since 2002, the company provides comprehensive preclinical and research services across multiple scientific disciplines, including toxicology studies, bioanalytical assays, pharmaceutical analysis, and specialized laboratory testing. Headquartered in West Lafayette, Indiana, Inotiv operates through multiple subsidiaries such as Integrated Laboratory Systems, Envigo Global Services, and BASi Research Products Division, which enable the company to offer a wide range of scientific research and testing capabilities to government agencies.

Through federal contract awards, Inotiv has provided diverse services to agencies like the Environmental Protection Agency, Centers for Disease Control and Prevention, National Institutes of Health, and Department of Health and Human Services. The company's contract work primarily involves mammalian oral exposure studies, non-human primate acquisition and housing, pathology evaluations, laboratory services, and specialized screening tests such as Ames assays. Most of these contracts are firm fixed-price purchase orders or delivery orders, typically not set aside for specific business types. Inotiv has worked as both a prime and subcontractor, collaborating with organizations like Battelle Memorial Institute, ICF Incorporated, and Seattle Institute for Biomedical and Clinical Research on various toxicology, reproductive, and microscopic evaluation studies.

Regarding federal grant awards, Inotiv has received project grants focused on advanced biomedical research. Notable grants include a $1,835,034 award from the Department of Defense's Military Medical Research and Development program to develop an APOL1 mouse platform for researching focal segmental glomerulosclerosis and chronic kidney disease. Another significant grant from the National Institute of Environmental Health Sciences supported the development of innovative mutagenicity assessment methods using human cell systems. The company has also participated in sub-grant roles, such as performing a non-human primate study supporting a Stanford University NIH Program Project Grant investigating pulmonary arterial hypertension.

Inotiv holds a significant Indefinite Delivery Contract (IDC) with the Environmental Protection Agency's Office of Research and Development, awarded in February 2022. This $7.8 million single-award, small business set-aside contract runs through January 2027 and focuses on mammalian oral exposure studies. Under this IDC, Inotiv has already received multiple firm fixed price delivery orders totaling over $1.5 million to conduct studies at EPA facilities in North Carolina and Ohio. The contract supports the EPA's Center for Computational Toxicology and Exposure in assessing potential health and environmental impacts of chemicals, generating critical data to inform regulatory programs and scientific research.

Quick answers

What is Inotiv, Inc.'s UEI?

Inotiv, Inc.'s Unique Entity ID (UEI) in SAM.gov is QYU7HDLDQK16.

What is Inotiv, Inc.'s CAGE code?

Inotiv, Inc.'s CAGE code is 58516.

What is Inotiv, Inc.'s primary NAICS code?

Inotiv, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Inotiv, Inc. located?

Inotiv, Inc.'s physical address in SAM.gov is 2701 Kent Ave, West Lafayette, IN 47906, USA.

Is Inotiv, Inc. registered in SAM.gov?

Yes. Inotiv, Inc.'s SAM.gov registration is active through June 4, 2027.

What is Inotiv, Inc.'s most recent federal award?

Inotiv, Inc.'s most recent federal contract award is Non-GLP 3-strain ames assay (68HE0B25P0363), from Office of Research and Development, on April 7, 2025.

On GovTribe

See Inotiv, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors